These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 16789795

  • 1. Zofenopril plus hydrochlorothiazide: Combination therapy for the treatment of mild to moderate hypertension.
    Zanchetti A, Parati G, Malacco E.
    Drugs; 2006; 66(8):1107-15. PubMed ID: 16789795
    [Abstract] [Full Text] [Related]

  • 2. Fixed combination of zofenopril plus hydrochlorothiazide in the management of hypertension: a review of available data.
    Borghi C, Cicero AF.
    Vasc Health Risk Manag; 2006; 2(4):341-9. PubMed ID: 17323587
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized "Z" Studies.
    Omboni S, Malacco E, Napoli C, Modesti PA, Manolis A, Parati G, Agabiti-Rosei E, Borghi C.
    Adv Ther; 2017 Apr; 34(4):784-798. PubMed ID: 28260186
    [Abstract] [Full Text] [Related]

  • 4. Zofenopril plus hydrochlorothiazide and irbesartan plus hydrochlorothiazide in previously treated and uncontrolled diabetic and non-diabetic essential hypertensive patients.
    Agabiti-Rosei E, Manolis A, Zava D, Omboni S, ZODIAC Study Group.
    Adv Ther; 2014 Feb; 31(2):217-33. PubMed ID: 24415271
    [Abstract] [Full Text] [Related]

  • 5. Zofenopril plus hydrochlorothiazide combination in the treatment of hypertension: an update.
    Borghi C, Omboni S.
    Expert Rev Cardiovasc Ther; 2014 Sep; 12(9):1055-65. PubMed ID: 25098297
    [Abstract] [Full Text] [Related]

  • 6. Fixed-dose combination of zofenopril plus hydrochlorothiazide vs. irbesartan plus hydrochlorothiazide in hypertensive patients with established metabolic syndrome uncontrolled by previous monotherapy. The ZAMES study (Zofenopril in Advanced MEtabolic Syndrome).
    Napoli C, Omboni S, Borghi C, ZAMES (Zofenopril in Advanced MEtabolic Syndrome) Study Group.
    J Hypertens; 2016 Nov; 34(11):2287-97. PubMed ID: 27653164
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of olmesartan medoxomil in patients with mild to moderate essential hypertension: the OLMEBEST Study.
    Barrios V, Boccanelli A, Ewald S, Girerd X, Heagerty A, Krzesinski JM, Lins R, Rodicio J, Stefenelli T, Woittiez A, Böhm M.
    Clin Drug Investig; 2007 Nov; 27(8):545-58. PubMed ID: 17638395
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Zofenopril plus hydrochlorothiazide fixed combination in the treatment of hypertension and associated clinical conditions.
    Omboni S, Malacco E, Parati G.
    Cardiovasc Ther; 2009 Nov; 27(4):275-88. PubMed ID: 19832845
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Combination therapy for hypertension: focus on high-dose olmesartan medoxomil (40 mg) plus hydrochlorothiazide.
    Rump LC, Sellin L.
    Expert Opin Pharmacother; 2010 Sep; 11(13):2231-42. PubMed ID: 20707758
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
    Levine B.
    Curr Med Res Opin; 2001 Sep; 17(1):8-17. PubMed ID: 11464450
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.